- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
March 14th, 2007
Though I'm not advising you to jump on the bandwagon and start investing willy-nilly in unprofitable IPOs, one company could ulimately profit from this trend: Motley Fool Rule Breakers recommendation Harris & Harris (Nasdaq: TINY).
As a publicly traded venture capital firm, the company has most of its money invested in small private nanotech start-ups, including Molecular Imprint, Nantero, and Nanosys (among many others). And while I have no indication that any of these companies are, in fact, planning to go public, today's more risk-tolerant environment bodes well for the prospect that they might.
|Related News Press|
Nanotech Grants Options September 22nd, 2016
Arrowhead Pharmaceuticals to Present at Upcoming September Conferences September 1st, 2016
Industrial Nanotech, Inc. Provides Shareholder Update August 22nd, 2016
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
Nanosciences: Genes on the rack October 21st, 2016
Nanoparticle vaccinates mice against dengue fever October 21st, 2016